Imaging, blood test aims to ID risk of stroke recurrence

A team in Scotland has developed a two-step method of identifying individuals at risk for recurrent intracerebral hemorrhage (ICH).

The team, led by Mark A Rodrigues with the Centre for Clinical Brain Sciences at the University of Edinburgh in Scotland, published findings online Jan. 10 in Lancet Neurology.

 “We aimed to develop a prediction model for the identification of cerebral amyloid angiopathy (CAA)-associated lobar intracerebral hemorrhage using CT features and genotype,” Rodrigues et al. wrote.

The research focused on 110 individuals who had died from brain bleeding, with a goal of identifying risk of cerebral amyloid angiopathy (CAA), which is linked to stroke and dementia.

Read more at Health Imaging: